This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled "Caution Concerning Forward-Looking...
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.
This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled "Caution Concerning Forward-Looking...
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, June 3, 2026 /CNW/ - Principal Technologies Inc. (TSXV: PTEC) (FWB:...
The company highlights increasing retail interest in quantitative futures strategies as investors seek alternatives to traditional market approaches.LOS ANGELES, June 3, 2026 /PRNewswire/ --...
The article breaks down pricing factors and helps readers understand what influences hearing aid expenses.SOUTHLAKE, Texas, June 3, 2026 /PRNewswire/ -- What should residents...
A limited-edition release inspired by patience, quiet wisdom and the extraordinary character that only time can revealNEW YORK, June 3, 2026 /PRNewswire/ -- Orphan...
BUFFALO, N.Y., June 3, 2026 /PRNewswire/ -- What does homeowners insurance really protect, and how can homeowners avoid costly surprises? That question is answered...
LAMESA, Texas, June 3, 2026 /PRNewswire/ -- The article explores how personalized care and lifestyle-focused evaluations support long-term overall wellness.
...
RENO, Nevada, June 03, 2026 (GLOBE NEWSWIRE) -- Globaltech Corporation (“Globaltech” or the “Company”) (OTCQB: GLTK), a U.S.-based technology holding company, is providing this Update to Shareholders to discuss: (i) how we are managing and operating the Company day to day, (ii) our near-term priorities with a long-term orientation, and (iii) how we responsibly and methodically approach innovation, including AI-enabled products and services.
Issued on behalf of Salazar Resources Limited (TSXV: SRL)VANCOUVER, BC, June 3, 2026 /PRNewswire/ -- USA News Group News Commentary — In mineral exploration, two...
Purpose-built for law enforcement, legal, government, healthcare, and financial services, VIDIZMO AI Intelligence Hub analyzes video, audio, documents, and images together, on your private...
The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be available in the U.S. in late 2026.